NextPharma

NextPharma is a prominent pharmaceutical contract development and manufacturing organization (CDMO) established in 2000. The company has expanded through strategic acquisitions, becoming a key outsourcing partner for pharmaceutical laboratories globally. NextPharma is dedicated to sustainable practices, with a goal to achieve CO2 neutrality by 2025. The company offers a wide range of services, including contract development, clinical trials supply, commercial manufacturing, and logistics support. NextPharma's product portfolio includes solids, hormones, liquids, antibiotics, and ophthalmic products, catering to diverse customer needs. With 10 manufacturing plants and four logistics sites across Europe, NextPharma employs over 2,400 people, with a strong emphasis on quality and regulatory compliance. In 2023, the company reported group sales of EUR 375 million, reflecting its robust financial performance and commitment to customer satisfaction.